ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Neutralization of Extracellular HMGB1 Suppresses Xeno-Immune Response and Delays Xenograft Rejection in a Rat-to Mouse Cardiac Xenotransplant Model

    G. Chen, J. Li, Y. Ruan, L. Wang, X. Huang, H. Guo, F. Gong

    Institue of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Background: Extracellular HMGB1 has been found to be a potent stimulator for adaptive immune responses. It has been reported that blockade of extracellular HMGB1 significantly…
  • 2013 American Transplant Congress

    Does Extended Criteria Donor Kidney Biopsy Predict Five-Year Patient and Graft Survival?

    G. Ng, S. Faerstain, A. Mehrnia, M. Kamgar, S. Bunnapradist, H. Gritsch

    UCLA David Geffen School of Medicine, Los Angeles, CA

    Purpose: Donor biopsy is frequently used to assess extended criteria donor (ECD) organ quality, but the effect on patient survival and graft survival is less…
  • 2013 American Transplant Congress

    Obesity Is a Major Barrier to Increasing Living Kidney Donation in the United States

    Z. Stewart

    Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA

    Background: The number of living kidney donors has failed to increase in over a decade. There is limited data on the percentage of living kidney…
  • 2013 American Transplant Congress

    Protective Effect of Carbon Monoxide-Releasing Molecules in Renal Ischemia-Reperfusion Injury Is Associated with Profound Inhibition of HMGB1 Cytoplasmic Translocation, The

    G. Chen, Y. Ruan, L. Wang, Y. Xiang, H. Guo, Y. Zhao

    Institue of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Background: carbon monoxide-releasing molecules (CORMs) can significantly protect against renal ischemia-reperfusion injury (IRI), however, the mechanisms have not been fully elucidated. HMGB1 can be passively…
  • 2013 American Transplant Congress

    Network Analysis Reveals Roles of Inflammation Factors in Different Phenotypes of Kidney Transplantation Patients

    D. Wu, M. Qian, M. Xu, R. Rong, T. Zhu

    Zhongshan Hospital, Fudan University, Shanghai Key Lab of Organ Transplantation, Shanghai, China

    BackgroundSystems-level characterization of inflammation in kidney transplantation remains incomplete. The present study aimed at identifying the inflammation proteins in phenotype transformation and assessing potential biomarkers…
  • 2013 American Transplant Congress

    Outcomes on the Simultaneous Pancreas-Kidney (SPK) Transplant Waitlist: A Competing Risk Analysis of the UNOS Database

    C. Schulze, M. Kamgar, E. Huang, G. Danovitch, S. Bunnapradist

    Kidney Transplant Research Center, UCLA David Geffen School of Medicine, Los Angeles, CA

    Objective: To determine the risk of competing outcomes for patients on the waitlist for Simultaneous Pancreas-Kidney (SPK) transplantation.Design: We used the OPTN/UNOS database to examine…
  • 2013 American Transplant Congress

    Donor CISH Polymorphism Is Associated with Allograft Outcomes in Kidney Transplantation

    S. Baek, J. Jeong, T. Koo, H. Kwon, Y. Kim, H. Park, M. Kim, H. Ro, Y. Hwang, C. Ahn, J. Yang

    Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Transplantation Research Institute, Seoul National University, Seoul, Korea; Department of Internal Medicine, Eulji General Hospital, Seoul, Korea; Transplantation Center, Seoul National University Hospital, Seoul, Korea

    Background: Cytokine-inducible SH-2 containing protein (CISH) is a member of suppressor of cytokine signaling (SOCS) family and involved in the negative regulation of IL-2 mediated…
  • 2013 American Transplant Congress

    Analysis of miRNAs in Peripheral Blood Mononuclear Cells: Potential Value of miR-182 as a Biomarker of Chronic Antibody Mediated Rejection

    K. Iwasaki, J. Ping, T. Yamamoto, Y. Miwa, M. Haneda, Y. Watarai, A. Katayama, K. Uchida, T. Kobayashi

    Department of Transplant Immunology, Nagoya University School of Medicine, Nagoya, Japan; Nagoya Daini Red Cross Hospital, Nagoya, Japan; Masuko Memorial Hospital, Nagoya, Japan

    [Purpose] All donor specific antibodies (DSAs) cannot cause chronic antibody-mediated rejection (CAMR), as grafts of renal transplant recipients with DSAs have shown different outcomes. Although…
  • 2013 American Transplant Congress

    Single Dose of Rituximab Results in a Long Lasting B-Cell Depletion in Peripheral Blood, without Affecting the Peripheral T-Cell Compartment, A

    E. Kamburova, H. Koenen, M. van den Hoogen, I. Joosten, L. Hilbrands

    Laboratory Medicine, Medical Immunology, Radboud University Medical Centre, Nijmegen, Netherlands; Department of Nephrology, Radboud University Medical Centre, Nijmegen, Netherlands

    The B-cell depleting antibody rituximab is widely used for the treatment of B-cell malignancies and autoimmune disorders. In organ transplantation, it is especially applied to…
  • 2013 American Transplant Congress

    PD-1 Analysis on CD28-CD27- CD4 T-Cells Allows Rapid Stimulation-Independent Assessment of CMV-Viremic Episodes in Transplant Recipients

    J. Dirks, H. Tas, T. Schmidt, S. Kirsch, B. Gärtner, U. Sester, M. Sester

    Dpt of Transplant and Infection Immunology, Saarland University, Homburg, Germany; Internal Med. IV, Homburg, Germany; Microbiology, Homburg, Germany

    We have previously shown that a high PD-1 expression on CMV-specific CD4 T-cells defines an anergic phenotype that is associated with CMV viremia in patients…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences